DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)



company name or ticker

Sector Update: Healthcare

Insiders Are Buying These Speculative Biotech Stocks

Insiders Buy Shares at Agco, Ziopharm, and Mirati Therapeutics

Plus, a purchase at GulfSlope Energy.

Insiders Buy Shares at Agco, Ziopharm, and Mirati Therapeutics

Top Insider Trades: ZIOP AGCO MRTX GSPE

Why Ziopharm Oncology Inc. Shares Floundered

Ziopharm utilizes a secondary offering to raise cash for its ongoing clinical studies. Should investors consider buying into this weakness?

ZIOPHARM Announces $50M Offering of Common Stock

Shares of Ziopharm, Intrexon Quiet Following Presentation Showing HIL-12 is Fully Functional in Stud

Shares of Ziopharm, Intrexon Quiet Following Presentation Showing HIL-12 is Fully Functional in Study Assay

3 Red Flags for This Biotech IPO

Synthetic biology is one of the most important industries of the 21st century, but recent biotech IPO Intrexon may be overvalued given its near-term growth potential.

Healthcare Stocks Solidly in the Black; Ziopharm, Intrexon Close to Unveiling Prospective Cancer Tre

Healthcare Stocks Solidly in the Black; Ziopharm, Intrexon Close to Unveiling Prospective Cancer Treatments
See More Articles...